Pancreatic Cancer

>

Latest News

Higher CA19-9 levels appear to correlate with increased recurrence and mortality for specific patients with pancreatic cancer who undergo surgical resection.
Gene Test Modestly Improves CA19-9 Prognosis in Pancreatic Cancer Surgery

March 2nd 2024

Higher CA19-9 levels appear to correlate with increased recurrence and mortality for specific patients with pancreatic cancer who undergo surgical resection.

Investigators are currently evaluating treatment with IMM-1-104 in pancreatic cancer and other disease types associated with the RAS pathway as part of a phase 1/2a study.
IMM-1-104 Earns FDA Fast Track Designation in Pancreatic Cancer

February 22nd 2024

A retrospective cohort study from the Trans-Atlantic Pancreatic Surgery Consortium determined a sustained OS rate with modified FOLFIRINIX in patients with pancreatic ductal adenocarcinoma.
mFOLFIRINOX Plus Clinical Staging Consideration May Improve OS in PDAC

February 16th 2024

Patients with metastatic pancreatic ductal adenocarcinoma may now receive injectable irinotecan liposome in combination with 5-fluorouracil/leucovorin and oxaliplatin in the first-line setting, which has been approved by the FDA.
Frontline NALIRIFOX Approved by FDA in Metastatic PDAC

February 13th 2024

Investigators of the AMPLIFY-201 trial hypothesized that ELI-002 2P may induce the expansion of functional tumor-directed KRAS-mutated specific T cells following tumor resection.
Cancer Vaccine Shows Efficacy and Safety Potential in PDAC and CRC

February 13th 2024

Video Series
Video Interviews
Podcasts
Diane M. Simeone, MD highlights the importance of multidisciplinary care, surgical practices, and early detection in pancreatic cancer care.
Oncology Peer Review On-The-Go

More News